retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial Agonism Based Therapies for | Current Cardiovascular Risk Reports Retatrutide (GLP-3): The Triple Agonist

Glutathione S-transferase (transferase pi) from research-subject placenta is identical or closely related to glutathione S-transferase (transferase rho) from erythrocytes

Lilly's next-gen Triple G (GLP-1/GIP/glucagon) agonist (Phase 1b, Phase 2): started recruiting for a Phase 3 trial this year approvals are expected by 2026

Compounded GLP-1s on Groupon The explosive popularity of glucagon-like peptide 1 (GLP-1) agonists like semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) for weight loss has spawned a dangerous trend: their availability as unregulated, Compounded GLP-1s versions on online platforms like Groupon

Glucagon-like peptide-1 receptor agonist use is associated with increased rates of acne vulgaris diagnosis in nondiabetic obese women but not men: a retrospective cohort study

CMS did not specify a required 3-month or 6-month lifestyle trial

PMID: 28436395